Tiliquinol

Tiliquinol

SCHEMBL553465

Cc1ccc([O-])c2ncccc12.Cc1ccc([O-])c2ncccc12.Cc1ccc([O-])c2ncccc12.[Al+3]

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.59
PSMD14 O00487 2/20 0.59
COPS5 Q92905 2/20 0.59
SLC6A2 P23975 1/20 0.59
CCR1 P32246 3/20 0.50
CCR8 P51685 3/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
CYP1A2 P05177 2/20 0.50
NPC1 O15118 2/20 0.50
ALDH1A1 P00352 1/20 0.50
ALOX15 P16050 1/20 0.50
HIF1A Q16665 1/20 0.50
HSD17B10 Q99714 1/20 0.50
HSP90AA1 P07900 1/20 0.50
CCR5 P51681 2/20 0.49
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
SLC40A1 Q9NP59 1/20 0.44
LMNA P02545 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tiliquinol SCHEMBL29444794 1.00 HTT (0.59) HTTPSMD14COPS5SLC6A2CCR1
Tiliquinol SCHEMBL23928052 0.96 HTT (0.59) HTTPSMD14COPS5SLC6A2CCR1
SCHEMBL29428976 0.85 PSMD14 (0.59) HTTPSMD14COPS5SLC6A2CCR1
SCHEMBL254157 0.85 PSMD14 (0.59) HTTPSMD14COPS5SLC6A2CCR1
Oxyquinoline SCHEMBL1715327 0.83 CCR1 (0.61) HTTPSMD14COPS5SLC6A2CCR1
SCHEMBL812451 0.81 HTT (0.70) HTTPSMD14COPS5SLC6A2CCR1
Lithium Ion SCHEMBL26097523 0.81 PSMD14 (0.59) HTTPSMD14COPS5SLC6A2CCR1
Cloxyquin SCHEMBL1714431 0.77 KDM4E (0.59) HTTSLC6A2CCR1CCR8L3MBTL1
SCHEMBL1714224 0.77 KMT2A (0.58) HTTCCR1CCR8L3MBTL1CYP1A2
SCHEMBL10159255 0.76 HTT (0.62) HTTPSMD14COPS5SLC6A2CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6423429-B1 None US disclosed
CN-118894862-A Indolo [3,2-B ] carbazole structural derivative and electroluminescent device thereof 西安欧得光电材料有限公司 2024-11-05 CN disclosed
CN-116946986-A Graphite-like phase carbon nitride composite material, preparation method thereof and quantum dot light emitting diode 广东聚华印刷显示技术有限公司 2023-10-27 CN disclosed
US-11778870-B2 Display device, electronic apparatus, and method of fabricating the display device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2023-10-03 US disclosed
CN-111816781-B Organic electroluminescent device, preparation method thereof and display device 京东方科技集团股份有限公司 2023-09-01 CN disclosed
US-11723263-B2 Organic electroluminescent element KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2023-08-08 US disclosed
CN-116410446-A Polymeric material, preparation method thereof, quantum dot light emitting diode and display device TCL科技集团股份有限公司 2023-07-11 CN disclosed
US-20230165065-A1 DISPLAY DEVICE, ELECTRONIC APPARATUS, AND METHOD OF FABRICATING THE DISPLAY DEVICE SEMICONDUCTOR ENERGY LAB (JP) 2023-05-25 US disclosed
CN-116156981-A Composite material, preparation method thereof and quantum dot light emitting diode TCL科技集团股份有限公司 2023-05-23 CN disclosed
US-11647666-B2 Organic electroluminescent element KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2023-05-09 US disclosed
US-20030047736-A1 Light emitting device and light emitting system NEC CORPORATION (JP) 2003-03-13 US disclosed
EP-1291676-A2 Radiation image detector KONICA CORPORATION (JP) 2003-03-12 EP disclosed
US-20030025084-A1 Radiation image detector KONICA CORPORATION (JP) 2003-02-06 US disclosed
US-6423429-B2 MADE BY CO-DEPOSITION OR SIMULTANEOUS EVAPORATION OF THE ORGANIC LAYER WITH A COMPOUND CAPABLE OF ACTING AS AN ELECTRON-ACCEPTING DOPANT; REDUCED ENERGY BARRIER IN THE HOLE INJECTION, LOW VOLTAGE CONSUMPTION REGARDLESS WORK FUNCTION Kido, Junji (JP) 2002-07-23 US disclosed
US-6396209-B1 MULTILAYER; REDUCIBLE COMPLEX, ANODE, CATHODE INTERNATIONAL MANUFACTURING AND ENGINEERING SERVICES CO., LTD. (JP) 2002-05-28 US disclosed
US-20010046611-A1 ORGANIC ELECTROLUMINESCENT DEVICES ROHM CO., LTD. (JP) 2001-11-29 US disclosed
EP-1011155-A2 Organic electroluminescent deivce Kido, Junji (JP) 2000-06-21 EP disclosed
EP-0948063-A2 Organic electroluminescent devices Kido, Junji (JP) 1999-10-06 EP disclosed
EP-0892587-A2 Organic EL device and method for production thereof TDK Corporation (JP) 1999-01-20 EP disclosed
US-5554450-A Organic electroluminescent devices with high thermal stability EASTMAN KODAK COMPANY (US) 1996-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11723263-B2 Organic electroluminescent element NR4A3, AFF4, NR4A1 HTT 3059/4885PSMD14 2778/4885COPS5 1298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.